Literature DB >> 22363161

Merkel Cell Carcinoma Concurrent with Bowen's Disease.

Hyun Chul Park1, Ho Song Kang, Kyoung Tae Park, Young Ha Oh, Hee Joon Yu, Joung Soo Kim.   

Abstract

Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous malignancy of the elderly and immunocompromised patients. It is occasionally found coexisting with other diseases, such as squamous cell carcinoma, basal cell carcinoma, actinic keratosis, miscellaneous adnexal tumors, and rarely Bowen disease. A 75-year-old woman presented with a 6-month history of an irregularly shaped erythematous patch on the left mandibular angle. Three months later, a 1.5×1.0 cm sized painless and rapidly growing erythematous nodule developed on the patch. Microscopically, the patch lesion was consistent with that of Bowen disease. The nodular lesion showed a number of small uniform hyperchromatic cells with scanty cytoplasm. It showed dense small-cell like nodular infiltration in the dermis. Immunohistochemical staining for cytokeratin 20 showed a positive result with a dot-like perinuclear pattern. Additionally, the result for thyroid transcription factor-1 was negative, which is positive in small cell neuroendocrine carcinoma. From these findings, we diagnosed this lesion as MCC concurrent with Bowen disease.

Entities:  

Keywords:  Bowen disease; Merkel cell carcinoma

Year:  2012        PMID: 22363161      PMCID: PMC3283857          DOI: 10.5021/ad.2012.24.1.77

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  9 in total

1.  Merkel cell carcinoma of the head and neck associated with Bowen's disease.

Authors:  P Schenk; K Konrad
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

2.  Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning.

Authors:  D Tsuruta; T Hamada; K Mochida; K Nakagawa; H Kobayashi; M Ishii
Journal:  Br J Dermatol       Date:  1998-08       Impact factor: 9.302

3.  Merkel cell carcinoma: report of three cases.

Authors:  O Okamoto; M Yoshiyama; S Takayasu; S Yokoyama
Journal:  J Dermatol       Date:  1998-01       Impact factor: 4.005

4.  Trabecular carcinoma of the skin.

Authors:  C Toker
Journal:  Arch Dermatol       Date:  1972-01

5.  Merkel cell carcinoma and chronic arsenicism.

Authors:  H C Lien; T F Tsai; Y Y Lee; C H Hsiao
Journal:  J Am Acad Dermatol       Date:  1999-10       Impact factor: 11.527

6.  Association between neuroendocrine (Merkel cell) carcinoma and squamous carcinoma of the skin.

Authors:  L G Gomez; S DiMaio; E G Silva; B Mackay
Journal:  Am J Surg Pathol       Date:  1983-03       Impact factor: 6.394

7.  Intraepidermal and dermal Merkel cell carcinoma with squamous cell carcinoma in situ: a case report with review of literature.

Authors:  Sasis Sirikanjanapong; Jonathan Melamed; Rishi R Patel
Journal:  J Cutan Pathol       Date:  2009-08-21       Impact factor: 1.587

8.  Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component.

Authors:  K J Smith; H G Skelton; T T Holland; A M Morgan; G P Lupton
Journal:  Am J Dermatopathol       Date:  1993-12       Impact factor: 1.533

9.  Trabecular carcinoma of the skin: an ultrastructural study.

Authors:  C K Tang; C Toker
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

  9 in total
  2 in total

1.  Incidental Merkel cell carcinoma in a cutaneous horn: a case report.

Authors:  Brian A Schick; Joshua S Tobe; Mariamma G Joseph; Tyler B Rouse; Manal Y Gabril
Journal:  Dermatol Pract Concept       Date:  2015-01-30

2.  Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice.

Authors:  Monique E Verhaegen; Paul W Harms; Julia J Van Goor; Jacob Arche; Matthew T Patrick; Dawn Wilbert; Haley Zabawa; Marina Grachtchouk; Chia-Jen Liu; Kevin Hu; Michael C Kelly; Ping Chen; Thomas L Saunders; Stephan Weidinger; Li-Jyun Syu; John S Runge; Johann E Gudjonsson; Sunny Y Wong; Isaac Brownell; Marcin Cieslik; Aaron M Udager; Arul M Chinnaiyan; Lam C Tsoi; Andrzej A Dlugosz
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.